Insider Trading March 16, 2026

AIRO Group CFO Sells $205,974 in Shares to Meet RSU Tax Withholding

Mariya Pylypiv disposed of 20,078 shares on March 12, 2026; AIRO subsidiary wins $1.9M U.S. Navy training contract

By Sofia Navarro AIRO
AIRO Group CFO Sells $205,974 in Shares to Meet RSU Tax Withholding
AIRO

AIRO Group Holdings CFO Mariya Pylypiv sold 20,078 shares of common stock on March 12, 2026, in a Form 4 filing, generating $205,974 at a weighted average price of $10.2587. The sale, executed to satisfy tax withholding related to restricted stock units, leaves Pylypiv with 49,887 directly held shares and an indirect 2,500-share stake held through Persistent LLC. Separately, AIRO’s Coastal Defense Inc. secured a one-year, $1.9 million IDIQ contract with the U.S. Navy to support realistic aviation and JTAC training.

Key Points

  • CFO Mariya Pylypiv sold 20,078 AIRO shares on March 12, 2026, raising $205,974 at a weighted average price of $10.2587.
  • The sale was executed to cover tax withholding from restricted stock unit settlements; Pylypiv now directly owns 49,887 shares and indirectly owns 2,500 shares via Persistent LLC.
  • AIRO’s subsidiary Coastal Defense Inc. secured a one-year IDIQ contract with the U.S. Navy worth $1.9 million to support aviation and JTAC training exercises.

Mariya Pylypiv, the Chief Financial Officer of AIRO Group Holdings, Inc. (AIRO), reported the sale of 20,078 shares of the company’s common stock on March 12, 2026, in a Form 4 filing with the Securities and Exchange Commission.

The shares were sold at a weighted average price of $10.2587, producing total proceeds of $205,974. Reported execution prices for the disposition ranged from $9.99 to $10.4716.

The filing notes the shares were sold specifically to satisfy tax withholding obligations tied to the settlement of restricted stock units. After completing the sale, Pylypiv directly holds 49,887 shares of AIRO Group Holdings common stock. She also maintains an indirect stake of 2,500 shares through Persistent LLC, of which she is identified as the sole member.

At the time of the report, AIRO shares were trading at $10.07, reflecting a 58% decline over the past 12 months. An InvestingPro analysis referenced in the filing indicates the stock appears undervalued at current levels and notes there are 11 additional ProTips available to subscribers that focus on the company’s financial position and market dynamics.


In related company news noted in the filing, AIRO’s subsidiary, Coastal Defense Inc., has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the U.S. Navy valued at $1.9 million. The agreement runs for one year and is intended to improve coordination between aircrews and Joint Terminal Attack Controllers (JTACs) in close air support scenarios.

According to the announcement, Coastal Defense, which operates within AIRO’s Training Division, will deliver specialized support services designed to raise the realism of Navy aviation and JTAC training exercises conducted in complex environments. The contract underscores AIRO’s involvement in military training programs through its Training Division.

The Form 4 filing and the company announcement together document both an insider share sale undertaken for tax purposes and a new government training-services contract that AIRO expects to fulfill through its Coastal Defense unit.

Risks

  • AIRO’s share price has declined 58% over the past year, highlighting potential market and valuation uncertainty for shareholders - impacts the equities market sector.
  • The material financial impact of the $1.9 million Navy contract on AIRO’s overall revenue and profitability is not specified in the filing - relevant to defense and government services sectors.
  • The insider sale was carried out to meet tax withholding obligations tied to restricted stock units; while the filing identifies the reason, such transactions can create uncertainty around insider liquidity events in the corporate governance and investor relations context.

More from Insider Trading

SEMrush Holdings President Disposes $4.8M in Class A Stock Mar 16, 2026 United Therapeutics CEO Executes Stock Sales and Option Exercise as Company Reports Phase 3 Success and $2B Buyback Mar 16, 2026 Abeona CFO Sells Small Stake as Gene Therapy Launch Progresses Mar 16, 2026 Dauch Director Purchases $182,000 of Stock as Company Completes Major Acquisition Mar 16, 2026 Investar director increases stake with $41,617 purchase as bank holding completes Wichita Falls deal Mar 16, 2026